International survey on high- and low-dose synacthen test and assessment of accuracy in preparing low-dose synacthen

Clin Endocrinol (Oxf). 2018 May;88(5):744-751. doi: 10.1111/cen.13559. Epub 2018 Feb 22.

Abstract

Objective: The short synacthen test (SST) is widely used to assess patients for adrenal insufficiency, but the frequency and protocols used across different centres for the low-dose test (LDT) are unknown. This study aimed to survey centres and test the accuracy of ten different synacthen preparation strategies used for the LDT.

Methods: Members of 6 international endocrine societies were surveyed regarding diagnostic tests used for adrenal insufficiency, and in particular the SST. Synacthen was diluted for the LDT and concentrations measured using a synacthen ELISA.

Results: Survey responses were received from 766 individuals across 60 countries (52% adult, 45% paediatric endocrinologists). The SST is used by 98% of centres: 92% using high-dose (250 μg), 43% low-dose and 37% both. Ten low-dose dilution methods were assessed and variation in synacthen concentration was demonstrated with intramethod coefficients of variation (CV) ranging from 2.1% to 109%. The method using 5% dextrose as a diluent was the least variable (CV of 2.1%). The variation in dilution methods means that the dose of synacthen administered in a LDT may vary between 0.16 and 0.81 μg.

Conclusions: The high-dose SST is the most popular diagnostic test of adrenal insufficiency, but up to 72% of paediatric endocrinologists use a LDT. There is considerable variation observed both within and between low-dose synacthen dilution methods creating considerable risk of inaccurate dosing and thereby invalid results.

Keywords: dilution; low-dose synacthen; pituitary-adrenal function tests; questionnaires; surveys.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Insufficiency / blood
  • Adult
  • Cosyntropin / analysis*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Male
  • Surveys and Questionnaires

Substances

  • Cosyntropin
  • adrenocorticotropin zinc